"administration frequency" is correct and usable in written English.
You can use this phrase when discussing the frequency at which something is administered. For example, "The administration frequency of the drug was 3 times per day."
Similarly, adverse effect reports for each drug were taken from FAERS, among them; patient data (demographics and administrative) and drug related data (name, indication, dosage, drug name, route of administration, frequency).
Moreover, this formulation possibly will be able to decrease the administration frequency due to prolonged drug release.
In conclusion, these results indicate that the dilution of gonadotropin in a 5% hyaluronan solution, reducing the administration frequency, improves the quantitative and qualitative superovulatory response of Marchigiana heifers.
Mt based VF-PLGA nanocomposites suggest the possibility of designing the oral and controlled release formulations to minimize the drug administration frequency and the occurrence of side effect thereby increasing the effectiveness of drug and hence improving patient compliance.
The ophthalmic formulations on the market suffer from poor bioavailability, and it would therefore be useful to design a new formulation which is able to prolong the residence time and reduce the administration frequency.
Osmotic pump preparations can minimize administration frequency and improve the medication compliance and effectiveness for patients.
Many efforts have been devoted to the development of oral sustained-release systems that can not only improve drug bioavailability leading to better efficacy and less administration frequencies but also decrease the fluctuation of plasma drug concentration to lower side effects [2].
GA has been tested in two independent sets of experiments at different doses and administration frequencies, as indicated.
After the initial vaccine administration, frequencies of Ad5-specific CD8+ T-cells in blood increased significantly above pre-vaccination frequencies in baseline Ad5 seropositive (p<0.0001) but not in baseline seronegative subjects as a group (Fig. 2A).
Mean ± SD haematocrit was 36.4 ± 3.7% over Weeks 12 24, and mean haematocrit during this period was > 36% for all dialysis subgroups and administration frequencies (data not shown).
Much recent effort has been focused on the development of "biobetter" molecules with extended plasma half-lives to reduce their administration frequencies and to extend their therapeutic windows.
